Straumann

Between 1954 and 1970, the company specialized in alloys used in timing instruments and in materials testing. Among Straumann's renowned inventions in this period were special alloys that are still used in watch springs today. A breakthrough in the use of non-corroding alloys for treating bone fractures prompted Dr Fritz Straumann to enter the fields of orthopedics and dental implantology, which began the second phase of the company's history.

1954
In the small town of Waldenburg, at the foot of the Swiss Jura, Reinhard Straumann founds the "Dr Ing. R. Straumann Research Institute AG".

1960
The Swiss Association for the Study of Internal Fixation (AO/ASIF) is looking for a company that is capable of providing materials for internal fixation implants - Dr H.C. Fritz Straumann, son of the company's founder, gets in touch.

Between 1970 and 1990, Straumann became a leading manufacturer of osteosynthesis implants. A management buy-out of the osteosynthesis division in 1990 led to the creation of Stratec (subsequently Synthes) as a separate company. 1990 thus marked the beginning of the Straumann Group as it is known today. Thomas Straumann, grandson of the founder, headed the remaining part of the firm, which employed just 25 people focused exclusively on dental implants.

Another major milestone in the company's history was in 1980 when Straumann established a partnership with the International Team for Implantology. The 1980s also marked the company's geographic expansion, with subsidiaries in Germany (1980) and the US (1989). The following are examples of achievements:

1974
The first dental implants are developed at the Institut Straumann and undergo successful clinical testing at the University of Berne.

1980
Under the aegis of Dr Fritz Straumann, Waldenburg, and Prof Schroeder, University of Berne, the International Team for Implantology, the ITI, is founded.

1990
After a management buy-out of the internal fixation division, Thomas Straumann focuses the activities of the Institut Straumann AG on the area of implant dentistry.

In 1998, Straumann Holding AG became a publicly traded company on the Swiss exchange. Through the acquisition of Kuros Therapeutics (2002) and Biora (2003), Straumann entered the promising field of oral tissue regeneration.

1998
The Straumann Holding AG goes public and is listed on the Swiss stock exchange.

2000
With the opening of the production site in Villeret, located in the Berne Jura, and the Technology Center in Waldenburg, new dimensions open up for the international Straumann group.

2002
Straumann acquires Kuros Therapeutics AG and extends its activities into the field of biomaterials.

2003
Straumann acquires the Swedish company Biora, a pioneer in the area of biologically based regeneration of dental tissue.

2004
Straumann moves into its new headquarters in Basel.

2011
Investment in Dental Wings, a developer and provider of CADCAM software and scanning technology, based in Canada.

2012
Straumann acquires Neodent from Brazil and extends its activities into the value Market.

2013
Straumann invests in Medentika and Createch – both companies are active in prosthetics.

2016
Straumann acquires Equinox,[6][7] in the fast-growing value segment in India.

The company also invests in the French implant maker Anthogyr[8] to address the non-premium segment in China.

2017
Straumann took a controlling interest in Medentika.

2018
Straumann invests in botiss biomedical[9][10][11] and fully acquires Createch.[12][11] The Group also gains control of T-Plus in Taiwan.[13]

Additionally, the Straumann Group entered the orthodontics field[14] and strengthened its digital capabilities through acquisitions and alliances: full acquisition of Dental Wings;[15] acquisition of ClearCorrect[14] (US-based provider of clear-aligner tooth correction solutions); investment in Geniova[16] (based in Spain and specialized in developing innovative hybrid aligner solutions); investment in Rapid Shape[17] (3D-printing systems); increased investment in Rodo Medical;[18] acquisition of Loop Digital Solutions;[19][20] partnership with 3Shape[21] (scanning and software solutions).

2019
The Group takes over French implant manufacturer Anthogyr.[22]

(as elected in the 2018 Annual General Shareholders Meeting; see also Trade Register of the Swiss Canton Basel-Stadt[24])

• Gilbert Achermann – Chairman of the Board
• Dr. h.c. Thomas Straumann – Vice Chairman of the Board, Member Compensation Committee
• Monique Bourquin – Member Compensation Committee
• Dr. Sebastian Burckhardt – Member Audit Committee, Secretary of the Board
• Ulrich Looser – Chair Compensation Committee
• Dr. Beat Lüthi – Chair Audit Committee
• Regula Wallimann – Member Audit Committee

(as of 2018; see also Trade Register of the Swiss Canton Basel-Stadt[24])

• Guillaume Daniellot – Chief Executive Officer
• Dr. Gerhard Bauer – Head Research, Development & Operations
• Wolfgang Becker – Head Distributor & Emerging Markets EMEA
• Robert Woolley – Head Sales North America
• Jens Dexheimer – Head Sales Europe
• Dr. Peter Hackel – Chief Financial Officer
• Holger Haderer – Head Marketing & Education
• Patrick Kok-Kien Loh – Head Sales Asia/Pacific
• Alastair Robertson – Global People Management & Development
• Petra Rumpf – Head Dental Service Organizations
• Matthias Schupp – Head Sales Latin America, CEO Neodent
• Dirk Reznik – Head Digital Business Unit
• Camila Finzi - Head Orthodontics Business Unit

All major components of the Straumann Dental Implant System are currently manufactured at Straumann's factory in Villeret, Switzerland.[25]

Villeret became operational in 2000. Continued global volume growth made it necessary to expand capacity, and a second production floor was fitted out in 2005. As a result, Villeret now operates two fully independent production lines, one producing surgical products (implants) and the other manufacturing components for the range of implant prosthetics (abutments). Villeret also houses the manufacturing unit for Straumann's third generation implant surface technology SLActive.

The North American headquarters in Andover[26] house Straumann's first manufacturing unit outside Switzerland and produces implant system components and instruments.

The 7,400-square-meter (80,000-square-foot) production area complements Straumann's current production unit in Villeret, Switzerland. It is also the home office location for Neodent, the Brazilian value implant Straumann acquired in 2013 as part of its product portfolio.

Headquarters and production facility[27] of the Neodent non-premium portfolio.

Straumann's production unit in Malmö is devoted primarily to the specialized manufacture of regenerative products.

In June 2003 Straumann acquired the Swedish company Biora,[28] which specialized in the manufacture of the protein-based products for tissue regeneration. The manufacture of Emdogain, a protein based gel for use in periodontal disease, is focused in Malmö.

Dental Wings[29] headquarters and digital equipment production facility

ClearCorrect[30] headquarters and clear aligners production facility

The sites in Markkleeberg (Germany),[31] Arlington (Texas, USA),[32] Narita (Japan)[33] and Shenzhen (China) host Straumann's centralized CADCAM facilities (a.k.a. etkon) for tooth restoration prosthetics.